Petmed Express Target of Unusually Large Options Trading (NASDAQ:PETS)

Petmed Express Inc (NASDAQ:PETS) saw some unusual options trading activity on Monday. Investors bought 6,116 put options on the stock. This represents an increase of 1,128% compared to the typical daily volume of 498 put options.

Shares of Petmed Express stock opened at $26.00 on Tuesday. The firm has a market capitalization of $392.20 million, a P/E ratio of 13.14 and a beta of 0.57. Petmed Express has a 52 week low of $15.00 and a 52 week high of $33.28. The firm’s 50 day moving average is $17.97 and its two-hundred day moving average is $18.06.

Petmed Express (NASDAQ:PETS) last announced its quarterly earnings results on Monday, October 21st. The company reported $0.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.07. The company had revenue of $69.94 million for the quarter, compared to analyst estimates of $69.65 million. Petmed Express had a net margin of 11.05% and a return on equity of 23.42%. The firm’s revenue was down 2.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.52 earnings per share.

Institutional investors have recently made changes to their positions in the business. Tyers Asset Management LLC increased its stake in Petmed Express by 20.7% in the second quarter. Tyers Asset Management LLC now owns 4,356 shares of the company’s stock valued at $68,000 after purchasing an additional 748 shares during the last quarter. Riverhead Capital Management LLC grew its position in shares of Petmed Express by 19.4% during the second quarter. Riverhead Capital Management LLC now owns 4,917 shares of the company’s stock worth $77,000 after acquiring an additional 800 shares during the last quarter. Flinton Capital Management LLC grew its position in shares of Petmed Express by 20.7% during the second quarter. Flinton Capital Management LLC now owns 5,544 shares of the company’s stock worth $87,000 after acquiring an additional 952 shares during the last quarter. Neuburgh Advisers LLC grew its position in shares of Petmed Express by 20.7% during the second quarter. Neuburgh Advisers LLC now owns 6,732 shares of the company’s stock worth $105,000 after acquiring an additional 1,156 shares during the last quarter. Finally, FMR LLC grew its position in shares of Petmed Express by 9,448.1% during the first quarter. FMR LLC now owns 5,156 shares of the company’s stock worth $118,000 after acquiring an additional 5,102 shares during the last quarter. Institutional investors own 97.46% of the company’s stock.

Several brokerages have commented on PETS. Craig Hallum increased their price target on shares of Petmed Express from $15.00 to $20.00 and gave the company a “hold” rating in a research note on Thursday, October 17th. BidaskClub upgraded shares of Petmed Express from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, ValuEngine upgraded shares of Petmed Express from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd.

Petmed Express Company Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Further Reading: Strangles

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.